Showing results (41-50 of 62) with videos related to
Sort By:
Pageof 7
Medicina (Kaunas, Lithuania)|May 27, 2026
Next-Generation In Vitro Pulmonary Platforms for Respiratory Disease Modelling and Therapeutic Development: Current Advances and Future ProspectsFariya Khan, Pratibha Verma, Aditya Singh, et al.Applied Biochemistry and Biotechnology|August 1, 2014
Purification, characterisation and cloning of a 2S albumin with DNase, RNase and antifungal activities from Putranjiva roxburghiiPrabhat Pratap Singh Tomar, Navneet S Chaudhary, Pushkar Priyadarshi, et al.Cancer Health Disparities|August 24, 2019
Looking at cancer health disparities without the colored lensesMohammad Aslam Khan, Girijesh Kumar Patel, Sanjeev Kumar Srivastava, et al.British Journal of Cancer|February 3, 2017
Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCKGirijesh Kumar Patel, Mohammad Aslam Khan, Arun Bhardwaj, et al.Immunotherapy|November 21, 2025
Ataxia Telangiectasia Mutated (ATM) gene alterations as biomarkers of response to immune checkpoint inhibitorsMaun R Baral, Hassan Abushukair, Maen Abdelrahim, et al.Pancreas|June 14, 2017
Exosomal Markers (CD63 and CD9) Expression Pattern Using Immunohistochemistry in Resected Malignant and Nonmalignant Pancreatic SpecimensMoh'd Khushman, Arun Bhardwaj, Girijesh Kumar Patel, et al.Cancers|October 13, 2021
TBX2 Drives Neuroendocrine Prostate Cancer through Exosome-Mediated Repression of miR-200c-3pGirijesh Kumar Patel, Sayanika Dutta, Mosharaf Mahmud Syed, et al.The Journal of Biological Chemistry|May 3, 2020
Co-targeting of CXCR4 and hedgehog pathways disrupts tumor-stromal crosstalk and improves chemotherapeutic efficacy in pancreatic cancerMohammad Aslam Khan, Sanjeev Kumar Srivastava, Haseeb Zubair, et al.Cancer Research|December 8, 2016
Glucose Metabolism Reprogrammed by Overexpression of IKKε Promotes Pancreatic Tumor GrowthHaseeb Zubair, Shafquat Azim, Sanjeev Kumar Srivastava, et al.British Journal of Cancer|November 27, 2021
MYB interacts with androgen receptor, sustains its ligand-independent activation and promotes castration resistance in prostate cancerSanjeev Kumar Srivastava, Mohammad Aslam Khan, Shashi Anand, et al.Pageof 7